Today's News

Increasingly popular products

Kumdang-2 injection and Royal Blood-Fresh from the Pugang Pharmaceutic Co., Ltd. have long secured a firm position in the international market.

Kumdang-2 injection and Royal Blood-Fresh were invented 20 and 15 years ago respectively, and they are still highly popular in the international market and the demand for them is on a constant rise.

As a vegetable immunity optimization material based on second- and third-stage processing technologies with various complex rare-earth elements, gold and platinum added to insam polysaccharide extracted from Kaesong Koryo insam of the DPRK, Kumdang-2 injection is specially efficacious for diseases of the digestive system including the liver and the pancreas and various cancerous diseases and for the prevention and treatment of cold and influenza. 

The injection, which is exported to different countries including Russia, Mongolia and Belarus, is saving many people from diseases. 

The same is the case with Royal-Blood Fresh.

As a health food made of fermented Korean soybean with chonggokkinase added to it, Royal-Blood Fresh prevents and treats cerebral thrombosis and cerebral haemorrhage, strengthens vascular wall, improves intelligence and acts as cardiac and blood purifier.

Developed in the 2010s, the product already distinguished itself in the international market, outrivalling foreign products at that time.

Unlike other blood purifiers, Royal-Blood Fresh causes no side effects including haemorrhage even if it is taken more than dosage and at any time, and it has excellent medicinal effects and remarkably lowers the relapse rate. The demand for the product is on a constant rise as its special efficacy has become known. 

Target is best product

In order to develop a world-class product, the developers of the Pugang Pharmaceutic Co., Ltd. have blazed a difficult path.

“The resolve and will to add brilliance to the country with our own product were the motive power for our advance and the spiritual pillar encouraging us to keep to the difficult path,” said Jon Sung Hun, director of the Pugang Pharmaceutic Co., Ltd.

He is the lead developer of Kumdang-2 injection.

According to him, the company, from the outset of its establishment, set a goal of developing a world-class product with soybean and Kaesong Koryo insam, whose efficacy is known worldwide, as the main raw materials and made dynamic efforts to attain it.

It was not easy to attain the high goal, but all the employees of the company kept rushing for the development of the product, thus bringing about today’s success.

Many foreign companies have volunteered to serve as agents and disseminators of the company, and the company is now redoubling its efforts to achieve a greater success.